Treatment for intoractable perianal dermatitis by CMC Zinc oxide ointment

Treatment for intoractable perianal dermatitis by CMC Zinc oxide ointment - CMC Zinc oxide ointment treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035421

Enrollment

Registered

2019-01-01

Start date

2016-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intractable perianal dermatitis

Interventions

We use ointment mixed CMC 30g and zinc oxide ointment 70g.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: intactable perianal drmatitis

Exclusion criteria

Exclusion criteria: Patients have allergy for zinc oxide ointment.

Design outcomes

Primary

Measure	Time frame
We evaluate the efficiency of treatment every week	—

Countries

Japan

Contacts

Public ContactYuhki Arai

Niigata University Dental and Medical Hospital Pediatric Surgery

arai@med.niigata-u.ac.jp025-227-2258

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026